Clene (NASDAQ:CLNN) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.47) by 64.9 percent. This is a 26.42 percent increase over losses of $(1.06) per share from the same period last year. The company reported quarterly sales of $27.000 thousand which missed the analyst consensus estimate of $52.833 thousand by 48.90 percent. This is a 70.33 percent decrease over sales of $91.000 thousand the same period last year.